Tofisopam (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05BA23
CAS registry number (Chemical Abstracts Service)
0022345-47-7
Chemical Formula
C22-H26-N2-O4
Molecular Weight
382
Therapeutic Categories
Anxiolytic agent
Benzodiazepine derivative
Chemical Name
5H-2,3-Benzodiazepin, 1-(3,4-dimetoxyphenyl)-5-etyl-7,8-dimetoxy-4-metyl-
Foreign Names
- Tofisopamum (Latin)
- Tofisopam (German)
- Tofisopam (French)
- Tofisopam (Spanish)
Generic Names
- Tofisopam (OS: JAN, DCF)
- EGYT 341 (IS)
- Tofisopam (PH: JP XVII)
Brand Names
- Grandaxin
Egis, Bulgaria; Egis, Georgia; Egis, Lithuania; Egis, Latvia; Egis, Serbia; Egis, Russian Federation; Egis, Slovakia; Egis Pharmaceuticals, Romania; Egis Praha, Czech Republic; Medimpex, Pakistan; Mochida Pharmaceutical, Japan; Searle, Egypt - Grandaxin 10%
Mochida Pharmaceutical, Japan - Grandaxin 50 mg
Egis, Hungary - Granpam
Towa Yakuhin, Japan - Isotan
Hanlim, South Korea - No Deprine
Alphamoun, Egypt - Tofisopam
Nichi-Iko Pharmaceutical, Japan; Nihon Generic, Japan; Sawai Seiyaku, Japan - Tofisopam 10%
Choseido Pharmaceutical, Japan; Tsuruhara Seiyaku Pharmaceutical, Japan
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.